Ad is loading...
MENU

PRTA Prothena Corp Forecast, Technical & Fundamental Analysis

a developer of novel antibodies

Industry Biotechnology
PRTA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
PRTA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

PRTA is expected to report earnings to fall 7.27% to -101 cents per share on February 13

Prothena Corp PRTA Stock Earnings Reports
Q4'24
Est.
$-1.02
Q3'24
Beat
by $0.08
Q2'24
Beat
by $2.28
Q1'24
Missed
by $0.16
Q4'23
Missed
by $0.08
The last earnings report on November 12 showed earnings per share of -110 cents, beating the estimate of -117 cents. With 115.10K shares outstanding, the current market capitalization sits at 774.85M.
A.I. Advisor
published General Information

General Information

a developer of novel antibodies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
77 Sir John Rogerson’s Quay
Phone
+353 12362500
Employees
173
Web
https://www.prothena.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VRSCX24.700.15
+0.61%
Voya SmallCap Opportunities Port R6
UBVVX91.170.46
+0.51%
Undiscovered Managers Behavioral Val R5
RLGYX10.78N/A
N/A
Russell Inv Global Equity Y
TCSHX14.48N/A
N/A
Transamerica Multi-Asset Income C
GCSVX10.70N/A
N/A
Geneva SMID Cap Growth Institutional

PRTA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PRTA has been loosely correlated with PEPG. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if PRTA jumps, then PEPG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRTA
1D Price
Change %
PRTA100%
+2.49%
PEPG - PRTA
53%
Loosely correlated
-1.57%
BEAM - PRTA
51%
Loosely correlated
-3.16%
DNLI - PRTA
50%
Loosely correlated
+0.33%
NAUT - PRTA
49%
Loosely correlated
+4.46%
RGNX - PRTA
46%
Loosely correlated
+0.73%
More